Hospital
Bronxcare Health System
Bronxcare Health System was paid $348.43M by Medicaid between Jan 2018 and Dec 2024, across 682 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 19% of everything it billed.
33Billing provider infoBRONXCARE HEALTH SYSTEM
BRONX, NY 10457
BRONX, NY 10457
33aNPI1417027558assigned 11/08/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$348.43M
24GClaims5,745,382
24DCodes billed682
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#4 of 231
Median peer was paid$561K
This provider vs. median621×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DEMARCO, VICTOR controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 303,852 | $15.52M | |
| 2019 | 611,974 | $29.33M | |
| 2020 | 1,078,700 | $53.81M | |
| 2021 | 1,144,861 | $60.41M | |
| 2022 | 864,466 | $80.71M | |
| 2023 | 889,043 | $62.42M | |
| 2024incomplete | 852,486 | $46.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 526,832 | 431,905 | $64.68M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 269,573 | 229,986 | $36.86M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.0% | 102,792 | 96,518 | $20.85M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.1% | 91,296 | 85,972 | $17.79M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 4.4% | 130,983 | 103,248 | $15.50M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.2% | 134,034 | 112,329 | $14.55M |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 3.1% | 14,198 | 12,016 | $10.90M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 43,604 | 41,670 | $10.27M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.2% | 38,946 | 36,422 | $7.51M |
| 36415 | Collection of venous blood by venipuncture | 1.7% | 357,168 | 83,431 | $6.04M |
| 80053 | Comprehensive metabolic panel | 1.5% | 239,928 | 140,449 | $5.35M |
| 97010 | 1.4% | 122,069 | 25,589 | $4.82M |
670 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 68,468 | $4.03M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 90,274 | $4.01M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 71,397 | $3.94M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.0% | 53,058 | $3.65M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 17,610 | $3.36M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | <1% | 106,011 | $3.28M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 3,338 | $3.05M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 25,893 | $3.02M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 32,724 | $2.90M |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | <1% | 5,180 | $2.73M |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 18,253 | $2.48M |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 24,019 | $2.47M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 3,310 | $2.43M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 29,437 | $2.08M |
| S9485 | Crisis intervention mental health services, per diem | <1% | 1,767 | $2.05M |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 65,543 | $2.00M |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 26,888 | $1.90M |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | <1% | 9,209 | $1.88M |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | <1% | 1,898 | $1.87M |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 1,951 | $1.83M |
| 94760 | <1% | 68,685 | $1.73M | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 9,696 | $1.44M |
| 97162 | <1% | 11,301 | $1.43M | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 49,568 | $1.42M |
| 92551 | <1% | 47,225 | $1.40M | |
| 81002 | <1% | 53,096 | $1.39M | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 10,377 | $1.29M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 32,910 | $1.29M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 15,135 | $1.26M |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 8,469 | $1.20M |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 7,188 | $1.17M |
| 97014 | <1% | 49,587 | $1.10M | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 6,677 | $1.09M |
| 20610 | <1% | 8,939 | $1.07M | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 8,245 | $1.05M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 11,892 | $1.01M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 37,784 | $987K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 10,168 | $917K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 18,491 | $912K |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 8,471 | $889K |
| 99173 | <1% | 14,490 | $856K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 6,995 | $849K |
| 87536 | <1% | 11,953 | $848K | |
| 86703 | <1% | 51,455 | $812K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 6,629 | $764K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 26,008 | $764K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 8,083 | $751K |
| 59841 | <1% | 649 | $751K | |
| 85610 | <1% | 53,810 | $729K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 7,041 | $714K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 3,272 | $705K |
| 86885 | <1% | 26,962 | $696K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 806 | $688K |
| 76830 | Ultrasound, transvaginal | <1% | 11,049 | $677K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 3,403 | $666K |
| 80061 | Lipid panel | <1% | 63,604 | $664K |
| 97161 | <1% | 5,242 | $643K | |
| 73630 | <1% | 17,598 | $641K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 7,238 | $637K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 2,629 | $632K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 1,268 | $612K |
| 58558 | <1% | 495 | $589K | |
| 97164 | <1% | 5,309 | $571K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 37,837 | $558K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 25,719 | $498K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 34,959 | $493K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 5,598 | $492K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 3,844 | $487K |
| 83655 | <1% | 26,865 | $487K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 18,631 | $475K |
| 11721 | <1% | 7,338 | $469K | |
| 80051 | <1% | 48,316 | $459K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 4,949 | $456K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 5,944 | $453K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 2,330 | $451K |
| 90670 | <1% | 9,096 | $427K | |
| 93970 | <1% | 2,707 | $423K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 36,965 | $415K |
| 90651 | <1% | 2,982 | $409K | |
| 94060 | <1% | 4,714 | $398K | |
| 52000 | <1% | 642 | $397K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 7,929 | $395K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 6,373 | $391K |
| J3490 | Unclassified drugs | <1% | 63,307 | $377K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 3,239 | $374K |
| 86592 | <1% | 65,718 | $348K | |
| 86901 | <1% | 27,038 | $346K | |
| 12001 | <1% | 1,505 | $343K | |
| 90697 | <1% | 3,205 | $333K | |
| 76818 | <1% | 3,768 | $332K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 35,040 | $327K |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 8,404 | $320K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 15,003 | $320K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 159,847 | $313K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,928 | $310K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 72,505 | $304K |
| 86900 | <1% | 27,038 | $303K | |
| 81025 | <1% | 20,512 | $302K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 9,086 | $300K |
| J2794 | Injection, risperidone (risperdal consta), 0.5 mg | <1% | 1,304 | $299K |
| 10060 | <1% | 1,564 | $293K | |
| 99381 | <1% | 2,181 | $292K | |
| 76641 | <1% | 3,969 | $292K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 6,385 | $291K |
| 87210 | <1% | 25,986 | $288K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 562 | $284K |
| 51741 | <1% | 2,115 | $281K | |
| 12011 | <1% | 1,276 | $272K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 3,560 | $270K |
| 86803 | <1% | 39,119 | $265K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 14,891 | $265K |
| 99457 | <1% | 1,853 | $261K | |
| 90461 | <1% | 12,049 | $260K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 3,999 | $248K |
| 92134 | <1% | 7,533 | $247K | |
| 92083 | <1% | 3,485 | $243K | |
| 97803 | <1% | 2,068 | $238K | |
| 86706 | <1% | 35,349 | $235K | |
| 97166 | <1% | 1,901 | $223K | |
| 99454 | <1% | 2,837 | $220K | |
| 82607 | <1% | 25,504 | $216K | |
| 29581 | <1% | 1,914 | $211K | |
| 90686 | <1% | 15,895 | $205K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 1,111 | $202K |
| 73562 | <1% | 8,929 | $201K | |
| 20550 | <1% | 1,263 | $201K | |
| 58100 | <1% | 700 | $199K | |
| 97597 | <1% | 843 | $194K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 6,047 | $194K |
| C9290 | Injection, bupivacaine liposome, 1 mg | <1% | 367 | $193K |
| 90715 | <1% | 8,717 | $190K | |
| 90677 | <1% | 1,281 | $187K | |
| 90671 | <1% | 1,064 | $183K | |
| 99000 | <1% | 8,097 | $181K | |
| 76801 | <1% | 2,213 | $180K | |
| 99406 | <1% | 6,313 | $178K | |
| 77066 | Tomosynthesis, mammo | <1% | 2,207 | $176K |
| 97165 | <1% | 1,490 | $175K | |
| 11981 | <1% | 797 | $172K | |
| J2505 | Injection, pegfilgrastim, 6 mg | <1% | 36 | $169K |
| 92133 | <1% | 4,128 | $157K | |
| 73030 | <1% | 7,165 | $156K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 31,606 | $154K |
| GZHZZZZ | <1% | 78 | $151K | |
| 87340 | <1% | 35,228 | $151K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,097 | $141K |
| 73130 | <1% | 6,672 | $141K | |
| 0002A | <1% | 4,074 | $138K | |
| 12002 | <1% | 552 | $136K | |
| 87077 | <1% | 4,754 | $132K | |
| 77065 | Tomosynthesis, mammo | <1% | 2,193 | $132K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 1,311 | $128K |
| 83880 | <1% | 8,390 | $128K | |
| 84153 | <1% | 7,131 | $127K | |
| 82728 | <1% | 15,031 | $126K | |
| 90746 | <1% | 3,166 | $126K | |
| 86762 | <1% | 11,128 | $124K | |
| 93971 | <1% | 2,865 | $124K | |
| 11982 | <1% | 562 | $123K | |
| 57454 | <1% | 379 | $122K | |
| 69210 | <1% | 2,049 | $122K | |
| 76536 | <1% | 1,602 | $122K | |
| 86769 | <1% | 7,161 | $122K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 14,409 | $121K |
| 31575 | <1% | 1,359 | $119K | |
| 97802 | <1% | 1,202 | $119K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,547 | $116K |
| 36416 | <1% | 4,113 | $115K | |
| 0012A | <1% | 3,333 | $114K | |
| 92587 | <1% | 2,255 | $113K | |
| 71250 | <1% | 1,279 | $112K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13,409 | $112K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 10,689 | $111K |
| 96367 | <1% | 3,760 | $111K | |
| 70486 | <1% | 1,980 | $110K | |
| 84702 | <1% | 18,546 | $109K | |
| 58300 | <1% | 992 | $109K | |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 3,001 | $108K |
| 0001A | <1% | 3,879 | $108K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 1,573 | $107K |
| 97168 | <1% | 1,023 | $106K | |
| 86765 | <1% | 9,779 | $104K | |
| 76813 | <1% | 1,526 | $104K | |
| 29355 | <1% | 491 | $103K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 936 | $100K |
| G8981 | Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 2,747 | $98K |
| 83020 | <1% | 8,411 | $96K | |
| C1729 | Catheter, drainage | <1% | 1,157 | $95K |
| 73565 | <1% | 2,476 | $93K | |
| 36000 | <1% | 7,117 | $92K | |
| 84439 | <1% | 18,422 | $92K | |
| 82746 | <1% | 14,378 | $91K | |
| 88142 | <1% | 4,690 | $91K | |
| 90680 | <1% | 7,264 | $89K | |
| 90656 | <1% | 8,964 | $89K | |
| 29125 | <1% | 737 | $89K | |
| 58301 | <1% | 704 | $89K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 413 | $88K |
| 0011A | <1% | 3,121 | $87K | |
| 92557 | <1% | 4,270 | $87K | |
| 90619 | <1% | 668 | $86K | |
| 86140 | <1% | 11,584 | $85K | |
| 96415 | <1% | 794 | $85K | |
| 73221 | <1% | 472 | $84K | |
| 92550 | <1% | 3,190 | $83K | |
| 96417 | <1% | 1,413 | $83K | |
| 73610 | <1% | 5,262 | $83K | |
| 90691 | <1% | 1,047 | $81K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,086 | $80K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 37,064 | $80K |
| 86580 | <1% | 3,284 | $77K | |
| 90837 | Psychotherapy session, about an hour | <1% | 507 | $77K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 521 | $75K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 506 | $74K |
| 90620 | <1% | 791 | $74K | |
| 99205 | Prolong outpt/office vis | <1% | 556 | $74K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,487 | $74K |
| 76942 | <1% | 783 | $73K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 607 | $72K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 1,369 | $71K |
| 88104 | <1% | 830 | $69K | |
| 86704 | <1% | 9,756 | $69K | |
| C1769 | Guide wire | <1% | 684 | $68K |
| 90698 | <1% | 5,357 | $67K | |
| 99385 | <1% | 628 | $64K | |
| 87522 | Neg quan hep c or qual rna | <1% | 1,884 | $63K |
| HZ2ZZZZ | <1% | 124 | $63K | |
| 72100 | <1% | 3,107 | $62K | |
| 51798 | <1% | 463 | $61K | |
| 99386 | <1% | 561 | $61K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 1,251 | $61K |
| H0037 | Community psychiatric supportive treatment program, per diem | <1% | 56 | $60K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 1,028 | $59K |
| 99402 | <1% | 621 | $58K | |
| 87517 | <1% | 1,569 | $58K | |
| 94727 | <1% | 1,967 | $57K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 512 | $57K |
| 73110 | <1% | 3,284 | $57K | |
| 83970 | <1% | 1,539 | $56K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 18,787 | $56K |
| 76870 | <1% | 1,193 | $55K | |
| 86735 | <1% | 6,773 | $54K | |
| 92015 | Determination of refractive state | <1% | 2,806 | $54K |
| A4605 | Tracheal suction catheter, closed system, each | <1% | 862 | $54K |
| 90716 | <1% | 2,319 | $51K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 16,888 | $51K |
| 90734 | <1% | 2,154 | $51K | |
| 83001 | <1% | 3,531 | $50K | |
| 90649 | <1% | 1,231 | $50K | |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | <1% | 36 | $50K |
| 73140 | <1% | 2,786 | $50K | |
| 93017 | <1% | 540 | $49K | |
| A4649 | Surgical supply; miscellaneous | <1% | 4,168 | $47K |
| 82670 | <1% | 2,238 | $47K | |
| 82570 | <1% | 14,298 | $47K | |
| 90717 | <1% | 462 | $46K | |
| 73564 | <1% | 1,360 | $46K | |
| 71045 | Radiologic examination, chest; single view | <1% | 7,360 | $46K |
| 93296 | <1% | 617 | $45K | |
| 99453 | <1% | 749 | $45K | |
| 84146 | <1% | 3,377 | $43K | |
| 88304 | <1% | 1,815 | $43K | |
| 82043 | <1% | 11,825 | $43K | |
| 11055 | <1% | 295 | $42K | |
| 90707 | <1% | 2,670 | $42K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 5,133 | $41K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 539 | $40K |
| 83540 | <1% | 13,214 | $40K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,567 | $39K |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 112 | $39K |
| 95816 | <1% | 192 | $37K | |
| 72170 | <1% | 2,370 | $37K | |
| 83550 | <1% | 11,309 | $37K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 5,207 | $36K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 626 | $36K |
| 90710 | <1% | 1,678 | $35K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 197 | $35K |
| 76000 | <1% | 412 | $35K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 6,152 | $35K |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | <1% | 241 | $34K |
| 0064A | <1% | 911 | $34K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 36,216 | $34K |
| 71271 | <1% | 423 | $34K | |
| 11900 | <1% | 229 | $33K | |
| C1776 | Joint device (implantable) | <1% | 356 | $32K |
| 83002 | <1% | 2,230 | $32K | |
| 77062 | <1% | 622 | $32K | |
| D1120 | Dental cleaning, child | <1% | 769 | $32K |
| 59025 | Fetal non-stress test | <1% | 355 | $31K |
| 90633 | <1% | 4,374 | $30K | |
| 51702 | <1% | 168 | $30K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,605 | $30K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 368 | $30K |
| 73502 | <1% | 2,549 | $30K | |
| 92250 | <1% | 1,099 | $30K | |
| 96152 | <1% | 265 | $29K | |
| 86708 | <1% | 3,950 | $29K | |
| 87400 | <1% | 5,860 | $28K | |
| 87081 | <1% | 3,536 | $27K | |
| 88720 | <1% | 1,592 | $27K | |
| 20605 | <1% | 158 | $27K | |
| 92579 | <1% | 696 | $27K | |
| 72114 | <1% | 808 | $27K | |
| 76820 | <1% | 437 | $26K | |
| 90732 | <1% | 386 | $26K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 24 | $26K |
| 86787 | <1% | 3,396 | $26K | |
| 99051 | <1% | 1,351 | $25K | |
| 92567 | <1% | 2,927 | $25K | |
| 92060 | <1% | 340 | $25K | |
| 90839 | <1% | 182 | $25K | |
| 72141 | <1% | 257 | $24K | |
| 96127 | <1% | 3,448 | $23K | |
| 0004A | <1% | 744 | $23K | |
| 94729 | <1% | 1,972 | $23K | |
| 99201 | <1% | 353 | $22K | |
| 95800 | <1% | 374 | $22K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 152 | $22K |
| 93925 | <1% | 271 | $22K | |
| 86316 | <1% | 2,571 | $22K | |
| 72197 | <1% | 129 | $22K | |
| 88300 | <1% | 1,331 | $22K | |
| 82785 | <1% | 1,651 | $21K | |
| 80050 | General health panel | <1% | 832 | $20K |
| 91322 | <1% | 401 | $20K | |
| 73560 | <1% | 1,087 | $20K | |
| 96402 | <1% | 259 | $20K | |
| 74240 | <1% | 105 | $19K | |
| 72110 | <1% | 1,172 | $19K | |
| 86705 | <1% | 3,200 | $19K | |
| 87070 | <1% | 2,625 | $19K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 1,549 | $19K |
| 70491 | <1% | 153 | $18K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 742 | $18K |
| 29827 | <1% | 12 | $18K | |
| 84165 | <1% | 3,335 | $18K | |
| 88141 | <1% | 1,187 | $17K | |
| 92227 | <1% | 380 | $17K | |
| 80076 | <1% | 746 | $17K | |
| 77080 | <1% | 783 | $17K | |
| 95012 | <1% | 1,454 | $17K | |
| 86038 | <1% | 3,787 | $17K | |
| 88307 | <1% | 181 | $17K | |
| A4624 | Tracheal suction catheter, any type other than closed system, each | <1% | 633 | $16K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 87 | $16K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 57 | $16K |
| 93225 | <1% | 223 | $16K | |
| 84480 | <1% | 4,678 | $16K | |
| J1631 | Injection, haloperidol decanoate, per 50 mg | <1% | 2,477 | $15K |
| 82784 | <1% | 1,418 | $15K | |
| 82533 | <1% | 999 | $15K | |
| 86376 | <1% | 1,222 | $15K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 7,845 | $15K |
| D1206 | Topical application of fluoride varnish | <1% | 711 | $15K |
| 83735 | <1% | 14,526 | $14K | |
| 82627 | <1% | 743 | $14K | |
| 92228 | <1% | 303 | $14K | |
| 99383 | <1% | 124 | $14K | |
| 0072A | <1% | 360 | $14K | |
| 90739 | <1% | 154 | $14K | |
| 84403 | <1% | 756 | $14K | |
| 90480 | <1% | 549 | $14K | |
| 99223 | Prolong inpt eval add15 m | <1% | 64 | $14K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 190 | $13K |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 27 | $13K |
| 73080 | <1% | 1,437 | $13K | |
| 86334 | <1% | 1,156 | $13K | |
| 83010 | <1% | 1,135 | $13K | |
| 73590 | <1% | 1,632 | $12K | |
| 93243 | <1% | 115 | $12K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 889 | $12K |
| 90714 | <1% | 901 | $12K | |
| 99221 | <1% | 106 | $12K | |
| 15853 | <1% | 279 | $12K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 192 | $12K |
| 74178 | <1% | 69 | $11K | |
| 95886 | <1% | 111 | $11K | |
| 29515 | <1% | 110 | $11K | |
| 94762 | <1% | 471 | $11K | |
| 90723 | <1% | 1,793 | $11K | |
| 85044 | <1% | 8,744 | $11K | |
| 92235 | <1% | 114 | $11K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 32,545 | $11K |
| 20611 | <1% | 27 | $11K | |
| 83615 | <1% | 4,415 | $11K | |
| 93321 | <1% | 205 | $11K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,770 | $11K |
| 0071A | <1% | 270 | $11K | |
| 80320 | <1% | 17,199 | $11K | |
| 93242 | <1% | 182 | $11K | |
| 72052 | <1% | 428 | $10K | |
| 73700 | <1% | 122 | $10K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 48 | $10K |
| 72131 | <1% | 201 | $10K | |
| 99408 | <1% | 304 | $10K | |
| 86161 | <1% | 1,246 | $10K | |
| 86880 | <1% | 527 | $10K | |
| 90662 | <1% | 600 | $10K | |
| A4615 | Cannula, nasal | <1% | 168 | $9K |
| 90696 | <1% | 1,544 | $9K | |
| 90744 | <1% | 1,394 | $9K | |
| 85651 | <1% | 7,974 | $9K | |
| 86431 | <1% | 2,463 | $9K | |
| 72040 | <1% | 364 | $9K | |
| 77049 | <1% | 74 | $9K | |
| Q0166 | Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen | <1% | 642 | $9K |
| 73090 | <1% | 1,273 | $9K | |
| 91320 | <1% | 119 | $9K | |
| 90648 | <1% | 1,865 | $9K | |
| 11056 | <1% | 64 | $8K | |
| 93299 | <1% | 76 | $8K | |
| 29826 | <1% | 13 | $8K | |
| 95811 | <1% | 12 | $8K | |
| 74018 | <1% | 923 | $8K | |
| 29130 | <1% | 78 | $8K | |
| D0120 | Dental checkup, returning patient | <1% | 314 | $8K |
| 83690 | <1% | 25,521 | $8K | |
| 57456 | <1% | 31 | $8K | |
| 88346 | <1% | 67 | $8K | |
| 73100 | <1% | 466 | $8K | |
| 0124A | <1% | 211 | $7K | |
| 71100 | <1% | 667 | $7K | |
| 88112 | <1% | 181 | $7K | |
| 84446 | <1% | 741 | $7K | |
| 83498 | <1% | 312 | $7K | |
| 99411 | <1% | 270 | $7K | |
| 94799 | <1% | 493 | $7K | |
| 86256 | <1% | 569 | $7K | |
| 85384 | <1% | 1,609 | $7K | |
| 90678 | <1% | 39 | $7K | |
| 70498 | <1% | 39 | $7K | |
| 82378 | <1% | 627 | $7K | |
| 84540 | <1% | 2,067 | $7K | |
| 0054A | <1% | 187 | $6K | |
| 80164 | <1% | 1,922 | $6K | |
| 90473 | <1% | 896 | $6K | |
| 86696 | <1% | 702 | $6K | |
| 0134A | <1% | 182 | $6K | |
| 84100 | <1% | 2,715 | $6K | |
| 82550 | <1% | 4,716 | $6K | |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | <1% | 64 | $6K |
| 82626 | <1% | 270 | $6K | |
| 85730 | <1% | 1,518 | $6K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,111 | $5K |
| 96368 | <1% | 625 | $5K | |
| 86225 | <1% | 1,462 | $5K | |
| 86147 | <1% | 327 | $5K | |
| 77061 | <1% | 191 | $5K | |
| 84630 | <1% | 915 | $5K | |
| D9995 | <1% | 184 | $5K | |
| 74022 | <1% | 997 | $5K | |
| 87390 | <1% | 357 | $5K | |
| 90681 | <1% | 255 | $5K | |
| Q3014 | Telehealth originating site facility fee | <1% | 427 | $5K |
| 69200 | <1% | 60 | $5K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 1,468 | $5K |
| 97032 | <1% | 520 | $5K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 6,181 | $5K |
| 92526 | <1% | 18 | $5K | |
| 93325 | <1% | 697 | $5K | |
| 99253 | <1% | 113 | $5K | |
| 84484 | <1% | 13,664 | $5K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 16 | $5K |
| 82131 | <1% | 447 | $4K | |
| D0330 | Panoramic radiographic image | <1% | 150 | $4K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,849 | $4K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,643 | $4K |
| 73060 | <1% | 486 | $4K | |
| 74183 | <1% | 12 | $4K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 1,790 | $4K |
| 82747 | <1% | 467 | $4K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,636 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 9,151 | $4K |
| 36573 | <1% | 63 | $4K | |
| 93926 | <1% | 77 | $4K | |
| 86003 | <1% | 1,001 | $4K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 14 | $4K |
| 84436 | <1% | 2,119 | $4K | |
| 84999 | <1% | 1,241 | $4K | |
| P9019 | Platelets, each unit | <1% | 13 | $4K |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 5,509 | $4K |
| 76882 | <1% | 76 | $4K | |
| 73552 | <1% | 418 | $4K | |
| C1888 | Catheter, ablation, non-cardiac, endovascular (implantable) | <1% | 14 | $3K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 42 | $3K |
| 90655 | <1% | 847 | $3K | |
| 92610 | <1% | 38 | $3K | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 5,615 | $3K |
| 73600 | <1% | 336 | $3K | |
| 83525 | <1% | 363 | $3K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,771 | $3K |
| 85362 | <1% | 4,929 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 48 | $3K |
| 80299 | <1% | 366 | $3K | |
| 77002 | <1% | 28 | $3K | |
| 84144 | <1% | 221 | $3K | |
| 93320 | <1% | 262 | $3K | |
| 90743 | <1% | 67 | $3K | |
| 93280 | <1% | 51 | $3K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 558 | $3K |
| 73620 | <1% | 291 | $3K | |
| 0052A | <1% | 65 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,834 | $2K |
| 80178 | <1% | 1,267 | $2K | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 2,923 | $2K |
| 93307 | <1% | 229 | $2K | |
| 95812 | <1% | 12 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 14,514 | $2K |
| 82270 | <1% | 483 | $2K | |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 450 | $2K |
| D0140 | Limited oral evaluation - problem focused | <1% | 344 | $2K |
| 86235 | <1% | 544 | $2K | |
| 85240 | <1% | 183 | $2K | |
| 20526 | <1% | 12 | $2K | |
| 82977 | <1% | 626 | $2K | |
| 92020 | <1% | 35 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,683 | $2K |
| 90849 | <1% | 29 | $2K | |
| C9257 | Injection, bevacizumab, 0.25 mg | <1% | 792 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 102 | $2K |
| 82150 | <1% | 1,164 | $2K | |
| 76825 | <1% | 13 | $2K | |
| 82525 | <1% | 248 | $2K | |
| 99401 | <1% | 57 | $2K | |
| 95911 | <1% | 13 | $2K | |
| 82105 | <1% | 470 | $2K | |
| 73521 | <1% | 129 | $2K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $2K |
| 80329 | <1% | 2,701 | $2K | |
| 73660 | <1% | 123 | $2K | |
| 82951 | <1% | 347 | $2K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 5,366 | $2K |
| 88108 | <1% | 292 | $2K | |
| 90657 | <1% | 625 | $2K | |
| 0051A | <1% | 42 | $2K | |
| 86340 | <1% | 201 | $2K | |
| 93282 | <1% | 24 | $2K | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 99 | $2K |
| 70496 | <1% | 36 | $2K | |
| 99254 | <1% | 26 | $2K | |
| 87040 | <1% | 2,879 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14,924 | $1K |
| 82960 | <1% | 336 | $1K | |
| 93226 | <1% | 26 | $1K | |
| 99218 | <1% | 12 | $1K | |
| 98960 | <1% | 87 | $1K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 186 | $1K |
| 90700 | <1% | 246 | $1K | |
| D0272 | Bitewings - two radiographic images | <1% | 118 | $1K |
| 93041 | <1% | 2,240 | $1K | |
| 90733 | <1% | 29 | $1K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 5,003 | $1K |
| 90785 | <1% | 15 | $1K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 5,905 | $1K |
| J2680 | Injection, fluphenazine decanoate, up to 25 mg | <1% | 366 | $1K |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 920 | $986.41 |
| 76821 | <1% | 16 | $982.53 | |
| 0031A | <1% | 23 | $923.98 | |
| 92002 | <1% | 14 | $899.07 | |
| 97124 | <1% | 17 | $861.36 | |
| 72074 | <1% | 51 | $860.73 | |
| 84681 | <1% | 53 | $854.91 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,470 | $832.40 |
| 99397 | <1% | 12 | $813.14 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,494 | $803.83 |
| 85247 | <1% | 43 | $795.27 | |
| 92555 | <1% | 31 | $777.65 | |
| 85246 | <1% | 23 | $761.71 | |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | <1% | 29 | $737.44 |
| 97116 | <1% | 41 | $733.93 | |
| 88161 | <1% | 76 | $708.02 | |
| 72050 | <1% | 28 | $683.21 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,491 | $670.63 |
| 82232 | <1% | 93 | $669.84 | |
| 87350 | <1% | 80 | $652.72 | |
| D1110 | Prophylaxis - adult | <1% | 15 | $630.00 |
| J1450 | Injection fluconazole, 200 mg | <1% | 213 | $627.68 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 5,701 | $625.08 |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 86 | $620.00 |
| 77047 | <1% | 12 | $614.73 | |
| 86709 | <1% | 197 | $608.19 | |
| 96900 | <1% | 31 | $606.58 | |
| 85007 | <1% | 2,060 | $600.78 | |
| 88312 | <1% | 12 | $576.27 | |
| 83516 | <1% | 86 | $544.52 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 6,538 | $529.16 |
| 73070 | <1% | 27 | $514.05 | |
| 86870 | <1% | 27 | $512.84 | |
| 71048 | <1% | 28 | $479.10 | |
| 84590 | <1% | 68 | $476.58 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | <1% | 41 | $476.10 |
| 86301 | <1% | 135 | $471.02 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 816 | $464.81 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 1,712 | $451.87 |
| 72070 | <1% | 15 | $442.47 | |
| 90672 | <1% | 19 | $441.17 | |
| 82390 | <1% | 92 | $411.99 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 877 | $407.53 |
| 93351 | <1% | 13 | $391.96 | |
| 72082 | <1% | 12 | $377.02 | |
| 99441 | <1% | 22 | $360.54 | |
| D9310 | <1% | 12 | $360.00 | |
| 86021 | <1% | 40 | $344.96 | |
| Q4106 | Dermagraft, per square centimeter | <1% | 13 | $333.51 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 238 | $319.53 |
| D0274 | Bitewings - four radiographic images | <1% | 25 | $312.00 |
| 85270 | <1% | 18 | $296.20 | |
| 85280 | <1% | 17 | $292.79 | |
| 92202 | <1% | 12 | $286.14 | |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 21 | $282.20 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 2,143 | $261.10 |
| D9430 | <1% | 13 | $260.00 | |
| 90713 | <1% | 39 | $259.61 | |
| 85303 | <1% | 41 | $221.71 | |
| 98925 | <1% | 17 | $209.57 | |
| D0270 | <1% | 64 | $200.00 | |
| 99442 | <1% | 16 | $198.47 | |
| 99382 | <1% | 12 | $198.12 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 2,324 | $174.95 |
| G0008 | Administration of influenza virus vaccine | <1% | 40 | $140.09 |
| 81050 | <1% | 90 | $135.69 | |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 34 | $134.02 |
| 83030 | <1% | 26 | $127.76 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,855 | $121.89 |
| 87420 | <1% | 1,214 | $116.22 | |
| 74021 | <1% | 30 | $113.58 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 244 | $108.71 |
| 82180 | <1% | 12 | $98.90 | |
| 96376 | <1% | 2,117 | $98.62 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 293 | $76.25 |
| 82140 | <1% | 25 | $74.87 | |
| J0720 | Injection, chloramphenicol sodium succinate, up to 1 gm | <1% | 12 | $65.36 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 189 | $62.58 |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 131 | $62.47 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,113 | $58.74 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 53 | $57.52 |
| 82009 | <1% | 2,109 | $55.55 | |
| 84134 | <1% | 28 | $55.54 | |
| 86790 | <1% | 14 | $55.51 | |
| 82103 | <1% | 12 | $51.25 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 160 | $49.29 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 63 | $36.78 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 44 | $32.73 |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 392 | $26.41 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 17 | $26.37 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 313 | $23.90 |
| 87449 | <1% | 47 | $15.60 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 262 | $14.88 |
| 86738 | <1% | 49 | $14.65 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 31 | $8.18 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | <1% | 95 | $7.96 |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 17 | $7.84 |
| 87207 | <1% | 36 | $5.99 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 258 | $5.88 |
| 89051 | <1% | 15 | $5.60 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 57 | $0.60 |
| J0735 | Injection, clonidine hydrochloride, 1 mg | <1% | 17 | $0.57 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 12 | $0.02 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 869 | $0.02 |
| 99429 | 0% | 1,909 | $0.00 | |
| J3535 | Drug administered through a metered dose inhaler | 0% | 128 | $0.00 |
| G8982 | Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 245 | $0.00 |
| A4580 | Cast supplies (e.g., plaster) | 0% | 12 | $0.00 |
| D1310 | 0% | 13 | $0.00 | |
| 83625 | 0% | 13 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 19 | $0.00 |
| 99080 | 0% | 11,999 | $0.00 | |
| 99499 | 0% | 467 | $0.00 | |
| 93793 | 0% | 20 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEMARCO, VICTOR (SENIOR VP- CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Bronxcare Health System | Bronx, NY | $62.38M |
| Bronxcare DR. Martin Luther King JR. Health Center | Bronx, NY | $60.39M |
| Bronxcare Health System | Bronx, NY | $13.04M |
| Bronxcare DR. Martin Luther King JR. Health Center | Bronx, NY | $7.31M |
| Bronxcare DR. Martin Luther King JR. Health Center | Bronx, NY | $6.55M |
| Bronxcare DR. Martin Luther King JR. Health Center | Bronx, NY | $6.04M |
| Bronxcare Health System | Bronx, NY | $4.30M |
| Bronxcare DR. Martin Luther King JR. Health Center | Bronx, NY | $3.14M |
| Bronxcare DR. Martin Luther King JR. Health Center | Bronx, NY | $511K |
| Bronxcare Health System | Bronx, NY | $420K |
| Bronxcare Health System | Bronx, NY | $403K |
| Bronxcare DR. Martin Luther King JR. Health Center | Bronx, NY | $392K |
| Bronxcare Health System | Bronx, NY | $13K |
| Bronxcare Health System | Bronx, NY | $12K |
| Bronxcare Special Care Center | Bronx, NY | $6K |
| Bronxcare Health System | Bronx, NY | $2K |
| Bronxcare Health System | Bronx, NY | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.